Latest healthcare innovations, hospital breakthroughs, and medical tourism updates
A landmark Singapore study published in Science Translational Medicine has uncovered a novel approach to treating aggressive BAP1-mutant cancers including mesothelioma and uveal melanoma. With China's precision oncology capabilities expanding rapidly, how do the two countries compare for international patients seeking treatment?
Read More →
The US is piloting subscription-based pricing for lenacapavir, the twice-yearly injectable HIV prevention shot. With a list price of over $42,000 per year in the US, how does China's growing PrEP landscape compare on cost, access, and options?
Read More →
China launched five medical research experiments into orbit on March 30, pushing toward the world's first space hospital. The program's ambition raises a question: how does China's emerging space medicine capability compare to decades of research in the US and Europe?
Read More →
Thailand's Ramathibodi and Samitivej hospitals have teamed up to bring CAR-T cell therapy — one of the world's most advanced cancer treatments — to Southeast Asian patients. But China has been running CAR-T programs for years. See how the two compare on cost, indications, and clinical experience.
Read More →
Egypt is rapidly positioning itself as a compelling alternative for international patients seeking quality healthcare combined with unforgettable travel experiences. See how it compares to China as a medical tourism destination.
Read More →
Insilico Medicine's $2.75B AI-driven drug discovery deal with Eli Lilly is the largest AI pharma collaboration in history. See how China stacks up as a hub for AI-powered clinical trials and drug development.
Read More →
India's medical tourism market surges to $13 billion in 2026 with 5 new government hubs. See how China compares in cost, quality, and accessibility for international patients seeking world-class care at accessible prices.
Read More →
Washington University's WU-CART-007 earned FDA Breakthrough Therapy designation in March 2026 for aggressive T-cell leukemias, posting a 91% response rate. We compare this with China's approved CAR-T landscape - and what it means for international patients.
Read More →
March 2026: US research reveals a common vitamin demonstrates significant efficacy against metabolic-associated fatty liver disease (MAFLD). We compare treatment approaches between China and the US, highlighting China's unique advantages for international patients.
Read More →
China's official tourism initiative officially launches with medical tourism and TCM wellness designated as core strategic pillars. Hainan Province positions itself as the nation's premier integrated health destination, combining ancient TCM heritage with cutting-edge modern medicine.
Read More →
With Japan-China relations strained and flight routes reduced, growing numbers of Japanese patients from northern Japan are seeking advanced treatment in China. Proton therapy, cancer treatment, and specialized surgery at 40-60% lower costs.
Read More →
China's National Medical Products Administration approved the world's first non-invasive brain-computer interface medical device in March 2026. With 36 patients regaining hand function and costs at one-fifth of Neuralink's invasive approach, China is taking a different path in the BCI race.
Read More →
Japan is on the verge of becoming the first country to approve stem cell therapies for diabetes treatment. The milestone could transform how doctors approach this chronic condition affecting millions worldwide.
Read More →
Singapore has made history by becoming the first country globally to achieve WHO's highest maturity level for medical device regulation.
Read More →